Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Myriad Genetics, Inc. (NASDAQ: MYGN).

Full DD Report for MYGN

You must become a subscriber to view this report.


Recent News from (NASDAQ: MYGN)

Myriad Genetics updates revenue guidance
Myriad Genetics (NASDAQ: MYGN ) is on watch after setting guidance below the expectations of analysts due to transitory issues identified with GeneSight and prenatal testing. More news on: Myriad Genetics, Inc., Consumer stocks news, Read more ...
Source: SeekingAlpha
Date: November, 07 2018 08:06
Myriad Genetics (MYGN) Q1 2019 Results - Earnings Call Transcript
Myriad Genetics, Inc. (MYGN) Q1 2019 Earnings Call November 06, 2018 4:30 pm ET Executives Scott Gleason - Myriad Genetics, Inc. Mark C. Capone - Myriad Genetics, Inc. R. Bryan Riggsbee - Myriad Genetics, Inc. Analysts Puneet Souda - Leerink Partners LLC William R. Quirk ...
Source: SeekingAlpha
Date: November, 06 2018 23:07
Myriad Genetics, Inc. 2019 Q1 - Results - Earnings Call Slides
The following slide deck was published by Myriad Genetics, Inc. in conjunction with their 2019 Q1 earnings Read more ...
Source: SeekingAlpha
Date: November, 06 2018 19:23
Myriad Genetics beats by $0.13, misses on revenue
Myriad Genetics (NASDAQ: MYGN ): Q1 Non-GAAP EPS of $0.43 beats by $0.13 ; GAAP EPS of -$0.01 beats by $0.05 . More news on: Myriad Genetics, Inc., Earnings news and commentary, Consumer stocks news, Read more ...
Source: SeekingAlpha
Date: November, 06 2018 16:10
Myriad Genetics Reports Fiscal First-Quarter 2019 Financial Results
Total First-Quarter Revenues of $202.3 Million, Up 13 Percent First-Quarter Diluted EPS of ($0.01) and Adjusted EPS of $0.43, Up 48 Percent Revised Full-Year Revenue Guidance to $855 to $865 Million; Maintained Diluted EPS Guidance of $0.40 to $0.45 and Adjusted EPS Guidance of $1....
Source: GlobeNewswire
Date: November, 06 2018 16:05
Notable earnings after Tuesday's close
ACAD , AAXN , AIZ , APEI , ASH , BEL , BOLD , BWXT , CHUY , COHR , CPE , CSLT , CUTR , CWH , DAR , DATA , DIOD , DK , DOOR , DPLO , DVN , DXC , DXCM , EGN , ENLC , ENLK , ENPH , ETSY , EVH , EVRI , FANG , FIVN , FTK , FTR , G , GDDY , GHDX , GLUU , HAL...
Source: SeekingAlpha
Date: November, 05 2018 17:35
Myriad Receives the Prestigious 2018 Utah Top Workplaces Award
SALT LAKE CITY, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced its recognition as a 2018 recipient of the Utah Top Workplaces Award .  This prestigious award is based on employe...
Source: GlobeNewswire
Date: November, 05 2018 07:05
Myriad Presents Two New Studies at the Western Section of the American Urological Association
New Data Demonstrate the Clinical Performance of the Prolaris ® and myRisk ® Hereditary Cancer Genetic Tests in Men with Prostate Cancer SALT LAKE CITY, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized ...
Source: GlobeNewswire
Date: November, 02 2018 07:05
Myriad Genetics down 12% on FDA nod for 23andme test for drug metabolism
Myriad Genetics ( MYGN -12.4% ) is down on more than double normal volume in apparent response to the FDA's approval of 23andme's molecular test aimed at informing on drug metabolism that may aid in the selection of drugs for certain patients based on their genetic profile (akin to a compa...
Source: SeekingAlpha
Date: November, 01 2018 12:01
Myriad Genetics to Present at the Stephens New York Investment Conference
SALT LAKE CITY, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced today that R. Bryan Riggsbee, CFO, is scheduled to present at the Stephens New York Investor Conference at 9:00 a.m. EDT on November...
Source: GlobeNewswire
Date: October, 30 2018 16:05

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-1431.0631.1531.3230.66566,386
2018-12-1331.3031.2531.8031.05623,333
2018-12-1231.0431.3031.9530.791,166,837
2018-12-1131.4930.7931.52530.24540,109
2018-12-1031.4231.2031.8230.79906,384

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1425,51667,64037.7232Short
2018-12-1322,82960,79037.5539Short
2018-12-1271,646231,39230.9630Cover
2018-12-1129,994102,13129.3682Cover
2018-12-1054,577136,04740.1163Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MYGN.


About Myriad Genetics, Inc. (NASDAQ: MYGN)

Logo for Myriad Genetics, Inc. (NASDAQ: MYGN)

Not available

 

Contact Information

 

 

Current Management

  • Peter D. Meldrum / President, CEO

Current Share Structure

  • Market Cap: $2,443,942,357 - 05/17/2018
  • Issue and Outstanding: 69,906,818 - 05/04/2018

 


Recent Filings from (NASDAQ: MYGN)

Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: August, 24 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 21 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 01 2018
Automatic shelf registration statement of securities of well-known seasoned issuers
Filing Type: S-3ASRFiling Source: edgar
Filing Date: August, 01 2018
Annual statement of changes in beneficial ownership of securities
Filing Type: 5Filing Source: edgar
Filing Date: July, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 29 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 12 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: MYGN)

Daily Technical Chart for (NASDAQ: MYGN)


Stay tuned for daily updates and more on (NASDAQ: MYGN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: MYGN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MYGN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MYGN and does not buy, sell, or trade any shares of MYGN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/